AstraZeneca nối lại thử nghiệm vắcxin ngừa COVID-19

Ngày 12/9, hãng dược phẩm liên doanh Anh-Thụy Điển AstraZeneca đã thông báo nối lại thử nghiệm lâm sàng theo cách thức ngẫu nghiên đối với vắcxin AZD1222 - một trong những loại vắcxin được đánh giá có tiềm năng nhất ngừa bệnh viêm đường hô hấp cấp COVID-19 hiện nay.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

EC thông qua nghị quyết thành lập “Schengen quân sự”

EC thông qua nghị quyết thành lập “Schengen quân sự”

Thế giới
(Baothanhhoa.vn) - Nghị viện châu Âu (EC) đã thông qua một nghị quyết quan trọng kêu gọi thành lập khu vực mang tên “Schengen quân sự”, nhằm tạo điều kiện cho lực lượng vũ trang và các trang thiết bị quân sự của Liên minh châu Âu (EU) có thể di chuyển tự do, nhanh...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh